Perrigo (PRGO) Amortization of Deferred Charges (2015 - 2026)
Perrigo (PRGO) reported Amortization of Deferred Charges of -$4.9 million for Q1 2026, up 23.44% year-over-year from -$4.0 million in Q1 2025, and up 10.91% quarter-over-quarter from -$5.5 million in Q4 2025.
Perrigo (PRGO) Amortization of Deferred Charges (2015 - 2026) Analysis & Trends
Perrigo (PRGO) has 6 years of Amortization of Deferred Charges data on file, last reported at -$4.9 million in Q1 2026.
- Amortization of Deferred Charges for Q1 2026 came in at -$4.9 million, up 23.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$35.7 million (up 4.29% YoY), and the FY2025 annual result was -$23.8 million, down 135.64% from the prior year.
- Amortization of Deferred Charges climbed to -$4.9 million in Q1 2026 per PRGO's latest filing, from -$5.5 million in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at -$4.9 million in Q1 2026 and troughed at -$18.9 million in Q4 2024.
- A 3-year average of -$8.9 million and a median of -$5.9 million in 2025 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2025 and 2026: Amortization of Deferred Charges surged 70.9% in 2025, then grew 23.44% in 2026.
- A 3-year view of Amortization of Deferred Charges shows it stood at -$18.9 million in 2024, then jumped by 70.9% to -$5.5 million in 2025, then advanced by 10.91% to -$4.9 million in 2026.
- Business Quant data shows PRGO's Amortization of Deferred Charges at -$4.9 million in Q1 2026, -$5.5 million in Q4 2025, and -$6.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -4.90 Mn |
| Mar 28, 2026 | -4.90 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Mar 29, 2025 | -6.40 Mn |
| Mar 29, 2025 | -6.40 Mn |
| Dec 31, 2024 | -18.90 Mn |
| Dec 31, 2024 | -18.90 Mn |
| Sep 30, 2017 | -6.60 Mn |
| Sep 30, 2017 | -6.60 Mn |
| Jul 1, 2017 | -5.40 Mn |
| Jul 1, 2017 | -5.40 Mn |
| Apr 1, 2017 | -6.40 Mn |
| Apr 1, 2017 | -6.40 Mn |
| Jul 2, 2016 | 8.40 Mn |
| Jul 2, 2016 | 8.40 Mn |
| Apr 2, 2016 | -6.70 Mn |
| Apr 2, 2016 | -6.70 Mn |
| Sep 26, 2015 | -8.50 Mn |
| Sep 26, 2015 | -8.50 Mn |